Head and Neck Surgery, Royal Devon and Exeter Hospital, Exeter, UK.
Genetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, UK.
J Clin Endocrinol Metab. 2020 Jul 1;105(7):e2398-407. doi: 10.1210/clinem/dgaa250.
The incidence of thyroid cancer is rising, and relatively little is known about modifiable risk factors for the condition. Observational studies have suggested a link between adiposity and thyroid cancer; however, these are subject to confounding and reverse causality. Here, we used data from the UK Biobank and Mendelian randomization approaches to investigate whether adiposity causes benign nodular thyroid disease and differentiated thyroid cancer.
We analyzed data from 379 708 unrelated participants of European ancestry in the UK Biobank and identified 1812 participants with benign nodular thyroid disease and 425 with differentiated thyroid carcinoma. We tested observational associations with measures of adiposity and type 2 diabetes mellitus. One and 2-sample Mendelian randomization approaches were used to investigate causal relationships.
Observationally, there were positive associations between higher body mass index (odds ratio [OR], 1.15; 95% confidence interval [CI], 1.08-1.22), higher waist-hip ratio (OR, 1.16; 95% CI, 1.09-1.23), and benign nodular thyroid disease, but not thyroid cancer. Mendelian randomization did not support a causal link for obesity with benign nodular thyroid disease or thyroid cancer, although it did provide some evidence that individuals in the highest quartile for genetic liability of type 2 diabetes had higher odds of thyroid cancer than those in the lowest quartile (OR, 1.45; CI, 1.11-1.90).
Contrary to the findings of observational studies, our results do not confirm a causal role for obesity in benign nodular thyroid disease or thyroid cancer. They do, however, suggest a link between type 2 diabetes and thyroid cancer.
甲状腺癌的发病率正在上升,而对于这种疾病的可改变风险因素知之甚少。观察性研究表明肥胖与甲状腺癌之间存在关联;然而,这些研究受到混杂因素和反向因果关系的影响。在这里,我们使用英国生物库(UK Biobank)的数据和孟德尔随机化方法来研究肥胖是否会导致良性结节性甲状腺疾病和分化型甲状腺癌。
我们分析了英国生物库中 379708 名无亲缘关系的欧洲血统参与者的数据,确定了 1812 名患有良性结节性甲状腺疾病和 425 名患有分化型甲状腺癌的患者。我们测试了肥胖和 2 型糖尿病与这些疾病的相关性。使用单样本和双样本孟德尔随机化方法来研究因果关系。
观察性研究表明,较高的体重指数(OR,1.15;95%可信区间[CI],1.08-1.22)、较高的腰围-臀围比值(OR,1.16;95%CI,1.09-1.23)与良性结节性甲状腺疾病呈正相关,但与甲状腺癌无关。孟德尔随机化并不支持肥胖与良性结节性甲状腺疾病或甲状腺癌之间存在因果关系,但它确实提供了一些证据表明,2 型糖尿病遗传易感性最高四分位数的个体患甲状腺癌的几率高于最低四分位数的个体(OR,1.45;CI,1.11-1.90)。
与观察性研究的结果相反,我们的结果并不证实肥胖与良性结节性甲状腺疾病或甲状腺癌之间存在因果关系。然而,它们确实表明 2 型糖尿病与甲状腺癌之间存在关联。